Align 24/7 Digestive Support review: the standard capsule

The linked front artwork visibly says twenty-eight capsules, and the Supplement Facts image shows twenty-eight one-capsule servings. The front image’s file name contains a different count token. That technical filename is not a reason to change what the actual picture says, nor does either image establish every retail pack available today. Our package-version guide follows this exact distinction. A review can identify the pictured record while leaving the selected retailer’s quantity unresolved. We inspected official online images, not a delivered bottle, seal, lot code or best-by marking, and did not establish which package a future order would supply.

The facts image names Bifidobacterium longum subsp. longum 35624 and prints 10 mg. Its footnote states one billion CFUs when manufactured and 1 × 10^7 probiotic cells until the best-by date. Those are different statements with different time points; this review does not replace them with a single undated “billions” claim. NIH’s probiotic reference explains why counts through a product’s life matter. The declaration also does not become a conversion formula for the blend mass in CoreAge’s review. A printed count describes a manufacturer record, not our measurement of the amount remaining after a particular shipment or storage history.

The current FAQ describes one billion live bacteria or CFUs at manufacture as 4 mg. It also says Align contains milk and sodium caseinate. The linked image instead lists microcrystalline cellulose, hydroxypropyl methylcellulose and less than two percent magnesium stearate and titanium dioxide, alongside its 10 mg declaration. This review cannot assign those differences to a confirmed old or new version. It also cannot infer milk-free status because one image lacks the FAQ wording. Ask the manufacturer which complete declaration applies to the exact selection. An unresolved ingredient question may matter clinically, and a product-page comparison cannot provide an allergy or medication-compatibility clearance.

The product page says no refrigeration is required. The FAQ describes keeping capsules in the original bottle at room temperature, stated there as 24°C/75°F, and advises against transferring them to pill keepers. It attributes a twenty-four-month shelf life and best-by stability to the product’s formulation and testing. Those are manufacturer statements, not our independent assessment of every temperature exposure or alternative container. The storage guide explains why “no refrigeration” does not mean all environments are equivalent. Retaining an exact instruction is different from inventing a safe duration in a warm parcel or deciding that a household package still meets a count claim.

Align’s product page describes advanced packaging, potency controls, a studied organism and doctor-recommendation claims. These concern different records and should not be assembled into a guarantee for one shopper. Its displayed overall star rating is explicitly based on incentivized reviews; we do not reproduce it as an independent editorial score or controlled outcome. Research about a strain also needs its actual preparation, population and measured endpoint. The Pendulum review illustrates another product with survey and preclinical claims, not an alternative outcome scale. Neither a familiar brand nor a more detailed panel establishes relief of adverse effects from semaglutide, tirzepatide or another medicine.

The manufacturer page offers retail purchase links, but this review did not verify a selected retailer’s current price, delivered total, recurring arrangement or return eligibility for the pictured twenty-eight-capsule product. A price from another count or Align formula would not resolve that gap. The bundle and subscription guide explains the difference between a package identity and an actual order commitment. No stock assurance or lowest-price claim is made. Before relying on a sales figure, its exact item, seller, quantity and purchase mode need to be clear. A manufacturer’s guarantee headline likewise does not replace the applicable terms for an untested retailer transaction.

The Align FAQ directs people who are severely ill or immune-compromised to ask a healthcare professional before use. NCCIH’s broader safety guidance provides context for that caution without diagnosing anyone or declaring all probiotics unsuitable in every circumstance. Our serious-illness guide keeps the care setting separate from package convenience. FDA’s consumer information also does not turn retail availability into premarket approval for safety and effectiveness. The useful result of this review is an identifiable public record and visible discrepancies. It is not permission to change prescribed care, wait through a concerning symptom or treat seller support as a clinical response channel.